UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

The Journal of infectious diseases, 2012-10, Vol.206 (8), p.1280-1290

2012

Volltextzugriff (PDF)

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers

BMC medicine, 2024-06, Vol.22 (1), p.259-13, Article 259

2024

Volltextzugriff (PDF)

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes

BMC medicine, 2023-05, Vol.21 (1), p.190-190, Article 190

2023

Volltextzugriff (PDF)

Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study

Rheumatology, 2016-10, Vol.55 (10), p.1901-1905

2016

Volltextzugriff (PDF)

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

Vaccine, 2008-03, Vol.26 (10), p.1375-1386

2008

Volltextzugriff (PDF)

Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials

Vaccine, 2015-01, Vol.33 (4), p.577-584

2015

Volltextzugriff (PDF)

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems

Vaccine, 2010-10, Vol.28 (43), p.7016-7024

2010

Volltextzugriff (PDF)

Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine

Vaccine, 2007-12, Vol.25 (51), p.8585-8597

2007

Volltextzugriff (PDF)

The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study

Tuberculosis (Edinburgh, Scotland), 2013-03, Vol.93 (2), p.179-188

2013

Volltextzugriff (PDF)

Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults

Clinical and vaccine immunology, 2014-05, Vol.21 (5), p.651-660

2014

Volltextzugriff (PDF)

Vaccines

The Lancet infectious diseases, 2008-06, Vol.8 (6), p.358

Vandepapelière, Pierre

2008

Volltextzugriff (PDF)

Vaccines

The Lancet infectious diseases, 2008-06, Vol.8 (6), p.358

Vandepapelière, Pierre

2008

Volltextzugriff (PDF)

Vaccines

The Lancet infectious diseases, 2008-05, Vol.8 (6), p.358-358

Vandepapelière, Pierre

2008

Volltextzugriff (PDF)

Vaccines

The Lancet infectious diseases, 2008, Vol.8 (6), p.358-358

Vandepapelière, Pierre

2008

Volltextzugriff (PDF)

Vaccines

The Lancet infectious diseases, 2008, Vol.8 (6), p.358-358

Vandepapelière, Pierre

2008

Volltextzugriff (PDF)

Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial

PloS one, 2014-12, Vol.9 (12), p.e113465-e113465

2014

Volltextzugriff (PDF)

Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1138-1143

2011

Volltextzugriff (PDF)

Book: Vaccines: frontiers in design and development

The Lancet infectious diseases, 2005-09, Vol.5 (9), p.543

Vandepapelière, Pierre

2005

Volltextzugriff (PDF)

Vaccines: frontiers in design and development

The Lancet infectious diseases, 2005-09, Vol.5 (9), p.543-543

Vandepapelière, Pierre

2005

Volltextzugriff (PDF)

Down‐regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid

Arthritis and rheumatism, 2013-02, Vol.65 (2), p.447-456

2013

Volltextzugriff (PDF)

Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults: A double-blind randomized trial

Human vaccines & immunotherapeutics, 2013-06, Vol.9 (6), p.1254-1262

2013

Volltextzugriff (PDF)

Randomized Controlled Trial of an Adjuvanted Human Papillomavirus (HPV) Type 6 L2E7 Vaccine: Infection of External Anogenital Warts with Multiple HPV Types and Failure of Therapeutic Vaccination

The Journal of infectious diseases, 2005-12, Vol.192 (12), p.2099-2107

2005

Volltextzugriff (PDF)

Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals

Journal of acquired immune deficiency syndromes (1999), 2012-01, Vol.59 (1), p.1-9

2012

Volltextzugriff (PDF)

Therapeutic vaccination against chronic viral infections

The Lancet infectious diseases, 2002-06, Vol.2 (6), p.353-367

Vandepapelière, Pierre

2002

Volltextzugriff (PDF)

Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults

Vaccine, 2005-04, Vol.23 (20), p.2591-2601

2005

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(43)
Buchkapitel
(3)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Science & Technology
(23)
Female
(21)
Life Sciences & Biomedicine
(21)
Adult
(19)
Male
(17)
Adolescent
(14)
Middle Aged
(14)
Biological And Medical Sciences
(13)
Immunology
(13)
Infectious Diseases
(13)
Double-Blind Method
(11)
Microbiology
(11)
Young Adult
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Medical Sciences
(9)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(9)
Vaccination
(8)
Vaccines
(8)
Virology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes

Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems

Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine

The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study

Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adults

Vaccines

Vaccines

Vaccines

Vaccines

Vaccines

Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial

Active immunisation of human interferon α transgenic mice with a human interferon α Kinoid induces antibodies that neutralise interferon α in sera from patients with systemic lupus erythematosus

Book: Vaccines: frontiers in design and development

Vaccines: frontiers in design and development

Down‐regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid

Immunogenicity and safety of different formulations of an adjuvanted glycoprotein D genital herpes vaccine in healthy adults: A double-blind randomized trial

Randomized Controlled Trial of an Adjuvanted Human Papillomavirus (HPV) Type 6 L2E7 Vaccine: Infection of External Anogenital Warts with Multiple HPV Types and Failure of Therapeutic Vaccination

Induction of strong HIV-1-specific CD4+ T-cell responses using an HIV-1 gp120/NefTat vaccine adjuvanted with AS02A in antiretroviral-treated HIV-1-infected individuals

Therapeutic vaccination against chronic viral infections

Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults

Suchergebnisse filtern